BR112014021433A2 - formulações farmacêuticas - Google Patents

formulações farmacêuticas

Info

Publication number: BR112014021433A2
Authority: BR; Brazil
Prior art keywords: pharmaceutical formulations; formulations; pharmaceutical
Prior art date: 2012-03-02

Application number

BR112014021433A

Other languages

English (en)

Inventor

Hildebrand-Cyrener Annegret

Moschner Katrin

Weingart Mario

Hoffmann Torsten

Original Assignee

Meda Pharma Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-03-02

Filing date

2013-03-01

Publication date

2017-07-18

2013-03-01 Application filed by Meda Pharma Gmbh & Co Kg filed Critical Meda Pharma Gmbh & Co Kg

2017-07-18 Publication of BR112014021433A2 publication Critical patent/BR112014021433A2/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

BR112014021433A 2012-03-02 2013-03-01 formulações farmacêuticas BR112014021433A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE102012004065		2012-03-02
PCT/EP2013/000615 WO2013127539A2 (de)	2012-03-02	2013-03-01	Pharmazeutische formulierungen

Publications (1)

Publication Number	Publication Date
BR112014021433A2 true BR112014021433A2 (pt)	2017-07-18

Family

ID=47845907

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR112014021433A BR112014021433A2 (pt)	2012-03-02	2013-03-01	formulações farmacêuticas

Country Status (13)

Country	Link
US (1)	US20150072006A1 (pt)
EP (1)	EP2819658A2 (pt)
JP (1)	JP2015508789A (pt)
CN (1)	CN104302277A (pt)
AU (1)	AU2013225352A1 (pt)
BR (1)	BR112014021433A2 (pt)
CA (1)	CA2864876A1 (pt)
EA (1)	EA201491477A1 (pt)
HK (1)	HK1204945A1 (pt)
MX (1)	MX2014010460A (pt)
NZ (1)	NZ628867A (pt)
WO (1)	WO2013127539A2 (pt)
ZA (1)	ZA201406407B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2664693C1 (ru) *	2017-10-05	2018-08-21	Федеральное государственное автономное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации	Способ предоперационной подготовки пациентов к офтальмологическим операциям

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4319649A1 (de) *	1993-03-18	1994-09-22	Asta Medica Ag	Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
DE19541405A1 (de) *	1995-11-07	1997-05-15	Asta Medica Ag	Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
DK1146862T3 (da) *	1999-01-29	2003-07-21	Disphar Int Bv	Farmaceutiske sammensætninger
US6610324B2 (en) *	1999-04-07	2003-08-26	The Mclean Hospital Corporation	Flupirtine in the treatment of fibromyalgia and related conditions
CA2550023C (en) *	2003-12-16	2011-04-12	Cnsbio Pty Ltd	Treatment of neuropathic pain
US7553858B2 (en) *	2003-12-17	2009-06-30	Meda Pharma Gmbh & Co. Kg	Combination of flupirtine and tramadol
DE102005054610B4 (de) *	2005-11-08	2010-06-10	Awd.Pharma Gmbh & Co. Kg	Flupirtin enthaltende Arzneimittelzubereitung mit kontrollierter Wirkstofffreisetzung
DE102006006532B4 (de) *	2006-02-10	2007-11-08	Biogenerics Pharma Gmbh	Pharmazeutische Zubereitung
JP2009539769A (ja) *	2006-06-02	2009-11-19	アリアドジーンセラピューティクスインコーポレイテッド	カペシタビン併用療法
US20080279930A1 (en) *	2007-05-07	2008-11-13	Bernd Terhaag	Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof

2013
- 2013-03-01 NZ NZ628867A patent/NZ628867A/en not_active IP Right Cessation
- 2013-03-01 EA EA201491477A patent/EA201491477A1/ru unknown
- 2013-03-01 EP EP13708685.6A patent/EP2819658A2/de not_active Withdrawn
- 2013-03-01 JP JP2014559128A patent/JP2015508789A/ja active Pending
- 2013-03-01 CA CA2864876A patent/CA2864876A1/en not_active Abandoned
- 2013-03-01 BR BR112014021433A patent/BR112014021433A2/pt not_active IP Right Cessation
- 2013-03-01 AU AU2013225352A patent/AU2013225352A1/en not_active Abandoned
- 2013-03-01 MX MX2014010460A patent/MX2014010460A/es unknown
- 2013-03-01 US US14/382,231 patent/US20150072006A1/en not_active Abandoned
- 2013-03-01 WO PCT/EP2013/000615 patent/WO2013127539A2/de active Application Filing
- 2013-03-01 CN CN201380012290.5A patent/CN104302277A/zh active Pending
2014
- 2014-09-01 ZA ZA2014/06407A patent/ZA201406407B/en unknown
2015
- 2015-06-12 HK HK15105588.0A patent/HK1204945A1/xx unknown

Also Published As

Publication number	Publication date
WO2013127539A2 (de)	2013-09-06
EA201491477A1 (ru)	2015-02-27
AU2013225352A1 (en)	2014-09-18
CA2864876A1 (en)	2013-09-06
EP2819658A2 (de)	2015-01-07
US20150072006A1 (en)	2015-03-12
ZA201406407B (en)	2016-01-27
NZ628867A (en)	2016-03-31
WO2013127539A3 (de)	2013-12-19
JP2015508789A (ja)	2015-03-23
CN104302277A (zh)	2015-01-21
HK1204945A1 (en)	2015-12-11
MX2014010460A (es)	2014-10-13

Legal Events

Date	Code	Title	Description
2017-12-26	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 5A ANUIDADE.
2018-04-17	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Publication	Publication Date	Title
DK3181128T3 (da)	2023-06-06	Farmaceutisk nilotinib-sammensætning
DK2694038T3 (da)	2019-08-19	Farmaceutisk sammensætning
DK3117837T3 (da)	2019-08-19	Antistofformuleringer
BR112014003052A2 (pt)	2017-03-01	composições farmacêuticas
DK2922877T3 (da)	2019-01-02	Forbedrede peptidlægemidler
HK1203812A1 (en)	2015-11-06	Novel pharmaceutical formulations
CO6930367A2 (es)	2014-04-28	Composiciones farmaceúticas
GT201200303A (es)	2014-04-29	Formulaciones farmacéuticas
CO6940426A2 (es)	2014-05-09	Formulaciones farmacéuticas
DK2897594T3 (da)	2020-06-29	Farmaceutisk sammensætning
DK2815752T3 (da)	2020-07-20	Oral farmaceutisk sammensætning
CL2014003283A1 (es)	2016-04-01	Formulación farmacéutica.
DK3178474T3 (da)	2020-06-08	Farmaceutisk formulering omfattende inositol
BR112014015885A8 (pt)	2017-07-04	preparação farmacêutica
SG11201509194SA (en)	2015-12-30	Radiomitigating pharmaceutical formulations
CO7091176A2 (es)	2014-10-21	Diagnóstico farmacéutico
DK3473255T3 (da)	2022-04-04	Farmaceutisk formulering omfattende ciclesonid
DK2931042T3 (da)	2021-06-07	Anthracyclinformuleringer
BR112015002646A2 (pt)	2018-02-06	composto e composição farmacêutica
DK3003401T3 (da)	2020-04-06	Farmaceutisk præparat
DK2877155T3 (da)	2021-01-18	Opioidformuleringer
DK2672817T3 (da)	2017-11-20	Forbedrede insekticide formuleringer
DK2854789T3 (da)	2019-09-16	Genotype- eller fænotype-baserede lægemiddelformuleringer
DK2908836T3 (da)	2019-12-16	Farmaceutisk formulering indeholdende curcuma
BR112013022907A2 (pt)	2016-09-13	composição farmacêutica